Study finds MPS2 scores are highly reproducible across DRE and non-DRE urine samples alike. “This study reinforces the value of MPS2 as a non-invasive diagnostic tool that delivers consistent and ...
Ignite Biomedical, Inc. ("Ignite"), a leader in AI-driven biomarker innovation for precision medicine, today announced the successful completion of analytical validation for its Tumor Necrosis ...
Background Although chest X-rays (CXRs) are widely used, diagnosing mitral stenosis (MS) based solely on CXR findings remains ...
Patients with a lung neoplasm, NSCLC histology, and treatment information in their notes were selected from a repository of over 27 million patients. From these, 200 were randomly selected for this ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company advancing cutting-edge cancer diagnostics, and Precision Pathology Services, a CAP/CLIA-certified anatomic and ...
Early Completion of Model-Assisted Designs for Dose-Finding Trials Accurate assessment of a molecular classifier that guides patient care is of paramount importance in precision oncology. Recent years ...
This link is the GuruFocus DCF Calculator on PCP: http://www.gurufocus.com/dcf/PCP. We can see that GuruFocus DCF Calculator gives PCP a fair value of $249.46 per ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company advancing innovative cancer diagnostics, announced that Precision Pathology Services, a CAP/CLIA-certified ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback